Sign in

CIK 0001551152

  • Large accelerated filer

AbbVie Inc.

Sign in to watch
Ticker
ABBV
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320375147
Phone
+1 847-932-7900
Business address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
  1. 4 Grant or award EVP, CHIEF HR OFFICER acquired 79,252 shares (grant or award)
  2. 4 Grant or award VICE CHAIRMAN acquired 109,103 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale EVP, CHIEF HR OFFICER sold 42,370 shares at an average $163.44 ($6,925,018)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Vice Chairman sold 79,801 shares at an average $150.90 ($12,041,780)
  13. 4/A Open-market sale EVP, Chief Strategy Officer sold 83,960 shares at $155.00 ($13,013,800)
  14. 4/A Open-market sale EVP, Chief Strategy Officer sold 25,000 shares at an average $147.29 ($3,682,189)
  15. 4 Open-market sale Vice Chairman sold 200,000 shares at an average $154.25 ($30,849,488)
  16. 4 Open-market sale EVP, Chief Strategy Officer sold 83,960 shares at $155.00 ($13,013,800)
  17. 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 2,876 shares (to pay taxes)
  18. 4 Open-market sale Vice Chairman sold 300,000 shares at an average $151.12 ($45,336,288)
  19. 4 Shares withheld for taxes SVP & Pres Global Allerg Aesth gave up 234 shares (to pay taxes)
  20. 4 Grant or award Director acquired 1,421 shares (grant or award)

Page 12 of 44 · 878 filings